Regulatory News
Monday, November 21, 2016
BRIEF-Oragenics says U.S. FDA grants fast track designation for development of co's AG013 for oral mucositis
* U.S. FDA grants fast track designation for the development
of Oragenics' AG013 for oral mucositis
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment